New England Capital Financial Advisors LLC Vaccitech PLC Transaction History
New England Capital Financial Advisors LLC
- $177 Billion
- Q1 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Vaccitech PLC stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 104 shares of VACC stock, worth $354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104
Previous 104
-0.0%
Holding current value
$354
Previous $384,000
35.42%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VACC
# of Institutions
17Shares Held
14.9MCall Options Held
0Put Options Held
0-
M&G PLC London, X05.2MShares$17.7 Million0.04% of portfolio
-
M&G Investment Management LTD London, X05.2MShares$17.7 Million0.07% of portfolio
-
Alphabet Inc. Mountain View, CA1.51MShares$5.16 Million0.23% of portfolio
-
Sc China Holding LTD N/A, K31.42MShares$4.84 Million0.52% of portfolio
-
Dc Funds, LP Mclean, VA642KShares$2.19 Million19.89% of portfolio
About Vaccitech plc
- Ticker VACC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,216,200
- Market Cap $127M
- Description
- Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...